Black Bird Biotech, Inc.
BBBT · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $291 | $191 | $173 | $233 |
| - Cash | $6 | $7 | $7 | $44 |
| + Debt | $748 | $729 | $719 | $670 |
| Enterprise Value | $1,034 | $913 | $885 | $858 |
| Revenue | $4 | $13 | $7 | $12 |
| % Growth | -69.5% | 75% | -38.9% | – |
| Gross Profit | $1 | $7 | $3 | $2 |
| % Margin | 36% | 54.1% | 45.8% | 12.5% |
| EBITDA | $42 | -$93 | -$82 | -$125 |
| % Margin | 1,059.3% | -721.7% | -1,104.3% | -1,036.8% |
| Net Income | -$131 | -$197 | -$451 | -$241 |
| % Margin | -3,333.2% | -1,524.2% | -6,109.6% | -1,995.4% |
| EPS Diluted | -0 | -0 | -0.001 | -0.001 |
| % Growth | 66.7% | 70% | -25% | – |
| Operating Cash Flow | -$5 | -$15 | -$99 | -$114 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$5 | -$15 | -$99 | -$114 |